Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
152.64B | 142.61B | 129.05B | 112.08B | 108.68B | Gross Profit |
56.12B | 51.78B | 46.79B | 40.02B | 37.47B | EBIT |
21.04B | 21.03B | 18.59B | 13.74B | 12.19B | EBITDA |
24.86B | 24.18B | 21.67B | 16.53B | 15.04B | Net Income Common Stockholders |
15.12B | 14.66B | 12.60B | 8.94B | 7.36B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
6.35B | 58.03B | 4.91B | 3.90B | 3.71B | Total Assets |
147.33B | 133.33B | 121.89B | 108.19B | 97.15B | Total Debt |
3.34B | 2.10B | 1.92B | 1.96B | 2.88B | Net Debt |
-3.01B | -3.52B | -2.99B | -1.93B | -781.00M | Total Liabilities |
56.14B | 50.36B | 48.02B | 42.72B | 37.56B | Stockholders Equity |
91.19B | 82.97B | 73.84B | 65.45B | 59.56B |
Cash Flow | Free Cash Flow | |||
23.39B | 10.67B | 9.03B | 14.54B | 8.10B | Operating Cash Flow |
23.72B | 13.05B | 11.91B | 16.98B | 9.99B | Investing Cash Flow |
-11.89B | -2.36B | -3.13B | -2.81B | -3.23B | Financing Cash Flow |
-7.98B | -6.70B | -5.42B | -4.46B | -3.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥217.55B | 19.90 | 2.44% | 6.15% | 2.06% | ||
76 Outperform | ¥534.35B | 21.41 | 1.88% | 9.15% | 8.60% | ||
76 Outperform | ¥415.98B | 51.64 | 0.20% | 27.33% | 91.27% | ||
75 Outperform | ¥435.97B | 28.60 | 1.61% | 7.49% | 1.09% | ||
73 Outperform | ¥192.90B | 19.22 | 1.93% | 19.53% | 9.84% | ||
69 Neutral | ¥23.26B | 32.30 | 1.84% | 7.60% | -6.99% | ||
62 Neutral | $11.72B | 10.43 | -7.10% | 2.91% | 7.41% | -7.94% |